{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:33:55Z","timestamp":1784342035013,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.fct.2025.115472","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:42:07Z","timestamp":1745390527000},"page":"115472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Experimental evaluation of favipiravir (T-705)-induced liver and kidney toxicity in rats"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-7948","authenticated-orcid":false,"given":"Menek\u015fe","family":"\u00dclger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-2207","authenticated-orcid":false,"given":"I\u015f\u0131l Tu\u011f\u00e7e","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2266-6601","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"Si\u0307pahi\u0307","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0515-9286","authenticated-orcid":false,"given":"G\u00f6zde \u00d6zge","family":"\u00d6nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2025.115472_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","article-title":"Favipiravir: a new and emerging antiviral option in COVID-19","volume":"76","author":"Agrawal","year":"2020","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.fct.2025.115472_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05706-z","article-title":"Effects of undernutrition on mortality and morbidity among adults living with HIV in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"21","author":"Alebel","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.fct.2025.115472_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11894-009-0007-5","article-title":"'Granulomatous liver disease'","volume":"11","author":"Bhardwaj","year":"2009","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.fct.2025.115472_bib4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/bdr2.2073","article-title":"Investigation of developmental toxicity of favipiravir on fetal bone and embryonic development","volume":"114","author":"Bilir","year":"2022","journal-title":"Birth Defects. Res."},{"key":"10.1016\/j.fct.2025.115472_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2017.12.020","article-title":"Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2025.115472_bib6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41598-018-37866-z","article-title":"'Synthesis of [(18)F]Favipiravir and Biodistribution in C3H\/HeN Mice as Assessed by Positron Emission Tomography'","volume":"9","author":"Bocan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2025.115472_bib7","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering"},{"issue":"17","key":"10.1016\/j.fct.2025.115472_bib8","article-title":"Favipiravir versus arbidol for COVID-19: a randomized clinical trial","volume":"3","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.fct.2025.115472_bib9","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"'Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral'","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.fct.2025.115472_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08923973.2023.2181712","article-title":"The effect of vitamin C supplementation on favipiravir-induced oxidative stress and proinflammatory damage in livers and kidneys of rats","volume":"45","author":"Do\u011fan","year":"2023","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.fct.2025.115472_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01897-20","article-title":"'A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19'","volume":"64","author":"Doi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2025.115472_bib12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41467-021-21992-w","article-title":"'Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model'","volume":"12","author":"Driouich","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fct.2025.115472_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23536","article-title":"'Assessment of toxicological effects of favipiravir (T-705) on the lung tissue of rats: an experimental study'","volume":"38","author":"Erba\u015f","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib14","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200160","article-title":"'Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines'","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.fct.2025.115472_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"'Favipiravir (T-705), a novel viral RNA polymerase inhibitor'","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2025.115472_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"'Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase'","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.fct.2025.115472_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10238-020-00671-y","article-title":"'Emerging treatment strategies for COVID-19 infection'","volume":"21","author":"Gavriatopoulou","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.fct.2025.115472_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cotox.2017.11.001","article-title":"DNA damage by oxidative stress: measurement strategies for two genomes","volume":"7","author":"Gonzalez-Hunt","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2022.09.011","article-title":"Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells","volume":"371","author":"Gunaydin-Akyildiz","year":"2022","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.fct.2025.115472_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.fct.2025.115472_bib21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/ijms17111826","article-title":"'Role of oxidative stress in drug-induced kidney injury'","volume":"17","author":"Hosohata","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2025.115472_bib22","unstructured":"Information provided by Dr. Reddy's Laboratories Limited. Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients. Responsible. s.l. : National library of medicine. Mar. https:\/\/beta.clinicaltrials.gov\/study\/NCT04529499?tab=results."},{"key":"10.1016\/j.fct.2025.115472_bib23","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1111\/jocd.14790","article-title":"'Angioedema after favipiravir treatment: two cases'","volume":"21","author":"Islamoglu","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.fct.2025.115472_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cid\/ciaa1176","article-title":"AVIFAVIR for treatment of patients with moderate coronavirus disease 2019 (COVID-19): interim results of a phase II\/III multicenter randomized clinical trial","volume":"73","author":"Ivashchenko","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.fct.2025.115472_bib25","article-title":"COVID-19 tedavisinde favipiravir ve hidroksiklorokinin Karaci\u011fer G\u00fcvenli\u011finin Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131","volume":"33","author":"\u0130zci-\u00c7etinkaya","year":"2020","journal-title":"Klimik J. Klimik Dergisi"},{"key":"10.1016\/j.fct.2025.115472_bib26","series-title":"Sleisenger and Fordtran's Gastrointestinal and Liver Disease","first-page":"739","article-title":"Gastrointestinal and hepatic manifestations of systemic disease","author":"Jain","year":"2006"},{"key":"10.1016\/j.fct.2025.115472_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"'Role of favipiravir in the treatment of COVID-19'","volume":"102","author":"Joshi","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.fct.2025.115472_bib28","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1073\/pnas.2014441117","article-title":"'Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity'","volume":"117","author":"Kaptein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2025.115472_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/01480545.2022.2066116","article-title":"'Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach'","volume":"46","author":"Kara","year":"2023","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib30","first-page":"173","article-title":"In vitro cytotoxic effects of some Covid-19 drugs on lung cancer cells","volume":"22","author":"Karaku\u015f","year":"2021","journal-title":"Trakya Univ. J. Nat. Sci."},{"key":"10.1016\/j.fct.2025.115472_bib31","first-page":"276","article-title":"Favipiravir-induced liver injury in patients with coronavirus disease 2019","volume":"9","author":"Kumar","year":"2021","journal-title":"J. Clin. Transl. Hepatol"},{"key":"10.1016\/j.fct.2025.115472_bib32","doi-asserted-by":"crossref","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The role of oxidative stress and antioxidants in liver diseases","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fct.2025.115472_bib33","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.2147\/DDDT.S259058","article-title":"Antiviral agent therapy optimization in special populations of COVID-19 patients","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.fct.2025.115472_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2019.110073","article-title":"Study on potential toxic material base and mechanisms of hepatotoxicity induced by Dysosma versipellis based on toxicological evidence chain (TEC) concept","volume":"190","author":"Liu","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.fct.2025.115472_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100159","article-title":"'Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019'","volume":"2","author":"Louchet","year":"2020","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"10.1016\/j.fct.2025.115472_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40268-020-00333-0","article-title":"Recommendations for dosing of repurposed COVID-19 medications in patients with renal and hepatic impairment","volume":"21","author":"Marra","year":"2021","journal-title":"Drugs R&D"},{"key":"10.1016\/j.fct.2025.115472_bib37","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00204-022-03306-1","article-title":"The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro","volume":"96","author":"Merches","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib38","series-title":"Granulomatous Liver Diseases","first-page":"183","author":"Mishima","year":"2019"},{"key":"10.1016\/j.fct.2025.115472_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1620\/tjem.251.87","article-title":"Uric acid elevation by Favipiravir, an antiviral drug","volume":"251","author":"Mishima","year":"2020","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.fct.2025.115472_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/intimm\/dxh044","article-title":"Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms","volume":"16","author":"Morimoto","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.fct.2025.115472_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113847","article-title":"'Toxic effects of mineral oil saturated hydrocarbons (MOSH) and relation to accumulation in rat liver'","volume":"177","author":"Nygaard","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2025.115472_bib43","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1007\/s00467-021-05111-x","article-title":"Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?","volume":"36","author":"Ozsurekci","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.fct.2025.115472_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.fct.2025.115472_bib45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ced.14953","article-title":"'Favipiravir-induced cutaneous adverse reactions in patients infected with COVID-19'","volume":"47","author":"Punyaratabandhu","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.fct.2025.115472_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/17425255.3.4.519","article-title":"'Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury'","volume":"3","author":"Ramaiah","year":"2007","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2012.07.034","article-title":"'Favipiravir (T-705) inhibits in vitro norovirus replication'","volume":"424","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fct.2025.115472_bib48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.fct.2025.115472_bib49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0046-8177(80)80026-8","article-title":"Iatrogenic hepatic injury","volume":"11","author":"Rubin","year":"1980","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.fct.2025.115472_bib50","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"'Macrophage plasticity, polarization, and function in health and disease'","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.fct.2025.115472_bib51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2025.115472_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1556\/650.2022.32455","article-title":"[Sinus bradycardia as a potential side effect of favipiravir treatment]","volume":"163","author":"Szigeti","year":"2022","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.fct.2025.115472_bib53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2021.12.001","article-title":"'Favipiravir exposure and pregnancy outcome of COVID-19 patients'","volume":"268","author":"T\u0131rm\u0131k\u00e7\u0131o\u011flu","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.fct.2025.115472_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1179\/acb.2001.051","article-title":"'Hepatic fibrin-ring granulomas in granulomatous hepatitis: report of four cases and review of the literature'","volume":"56","author":"Tjwa","year":"2001","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.fct.2025.115472_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijid.2020.11.142","article-title":"'Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: a randomized, comparative, open-label, multicenter, phase 3 clinical trial'","volume":"103","author":"Udwadia","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.fct.2025.115472_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101958","article-title":"The effect of erythropoietin and umbilical cord-derived mesenchymal stem cells on nerve regeneration in rats with sciatic nerve injury","volume":"114","author":"\u00dclger","year":"2021","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.fct.2025.115472_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2025.115235","article-title":"Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: an experimental study","volume":"196","author":"\u00dclger","year":"2025","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2025.115472_bib58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.fct.2025.115472_bib60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1389200218666171108154419","article-title":"Drug-Induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies","volume":"19","author":"Wu","year":"2018","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.fct.2025.115472_bib61","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jiac.2020.12.021","article-title":"Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19","volume":"27","author":"Yamazaki","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.fct.2025.115472_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107702","article-title":"Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: a multicenter, open-label, randomized trial","volume":"97","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691525002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691525002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:29:53Z","timestamp":1749760193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691525002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":61,"alternative-id":["S0278691525002406"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2025.115472","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental evaluation of favipiravir (T-705)-induced liver and kidney toxicity in rats","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2025.115472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115472"}}